Valethamate

Active pharmaceutical substance formulated in Jan Aushadhi generic products for Women's Health & Hormones treatment.

🧴 Clinical Application

For Intramuscular (IM) or Slow Intravenous (IV) administration ONLY by a qualified obstetrician in a labor room setting: 8 mg (1 ampoule) IM or slow IV administered when the cervix is dilated >=3-4 cm with regular rhythmic contractions. May be repeated at intervals of 30 to 45 minutes up to a maximum of 3 doses (24 mg total). Continuous monitoring of maternal heart rate, fetal heart rate, and uterine activity is required.

⚠️ Side Effects

Common: Dry mouth, transient tachycardia, flushing of skin, blurred vision, dizziness, thirst, and nausea. Rare/Severe: Marked maternal tachycardia (>140 bpm), severe urinary retention, paralytic ileus, and acute angle-closure glaucoma.

🛡️ Safety Warnings

Contraindicated in glaucoma, obstructive uropathy, intestinal obstruction, severe cardiac tachyarrhythmias, myasthenia gravis, and non-reassuring fetal status. Ensure adequate maternal hydration.